All of these observations point toward a crosstalk between a ROS–NF-κB–inflammation mediator in deciding the fate of ICC cells in a high glucose micro-environment, and the intervening role of curcumin. This evidence concerns the gene NFKB1 and intrahepatic cholangiocarcinoma.